•  
  •  
  •  
  •  

2026-05-29 05:22:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores

Keywords Selected:  LicensingAgreement

Stock Report

  • BHEL enters into LAToT with M/s NSTL-DRDO, Vishakhapatnam for GT-IRSS for Naval Vessels
  • Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
  • Apeejay Surrendra Park Hotels Ltd signs Hotel Management and Licensing Agreement
  • Safari Industries Secures 20-Year 'CARLTON' Brand License
  • Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist
  • Pritish Nandy Communications Ltd signs a licensing deal with Shemaroo Entertainment Ltd
  • Ajanta signs in-licensing agreement with Biocon for marketing Semaglutide in 26 countries
  • Lupin signs exclusive licensing agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
  • Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
  • Paras Defence and Space Technologies Ltd signs licensing agreement with DRDO for ToT
  • Brand Concepts Ltd executes amendment to agreement with ABG Juicy Couture LLC
  • Solarium Green Energy Ltd enters into Licensing Agreement for Transfer of Technology
  • Nibe Limited enters into licensing agreement with DRDO unit
  • Emcutix and WiQo Sign Exclusive Licensing Partnership to Revolutionize Derma-cosmetic Treatments in India
  • Paper Boat Apps, a Nazara Group Company, Expands Kiddopia's Content with Moonbug Entertainment Partnership
  • Alkem Laboratories enters into a licensing agreement with US-based Sonnet BioTherapeutics
  • Emcure Pharmaceuticals signs agreement with Gilead for the Manufacture and Global Supply of Lenacapavir
  • Dr. Reddy's signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
  • Minda Corporation signs Technology Licensing Agreement with Sanco
  • Dr. Reddy's signs non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan
  • Zydus announces non-exclusive patent licensing agreement with Takeda for 'Vault®' in India
  • Zydus and Dr. Reddy's announce licensing agreement for co‐marketing of Pertuzumab biosimilar
  • Amara Raja announces strategic Technology Collaboration with Gotion-InoBat-Batteries
  • Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India

Latest Post

  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025